One-year follow-up of the CAPSID randomized trial for high-dose convalescent plasma in severe COVID-19 patients.

J Clin Invest · 2022 · PMC9753994 · PMID 36326824

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

showed a trendno p-value reported

The trial showed a trend toward a better outcome in the CCP group but did not reach statistical significance and therefore missed the primary endpoint, which was defined as survival and no longer severe COVID-19 on day +21 after enrollment.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.